Optalysys welcomes Martin Gollery to the Business Development team based in Nevada, USA. Martin has joined as VP of Business Development for North America and will focus initially on building relationships with bioinformatics customers and partners.
Martin has been in Bioinformatics for 19 years. He co-founded the Nevada Center For Bioinformatics, is the author of several books and book chapters, has written several research papers that have been cited over 2,000 times, and has been a named participant in over $40,000,000 in Grants.
He was a Senior Scientist at Active Motif, and the Director of Bioinformatics Research at TimeLogic. He has presented talks, training and posters worldwide. He has been named a Governor’s Fellow, and has served on the Distinguished Panel of Experts for Bio-IT World for the past seven years before joining the Optalysys team.
Optalysys was founded in 2013 to develop revolutionary optical processing technology for the areas of Big Data processing and complex mathematics. The first product is launching at the end of 2017 and performs genetic sequence alignment.
Optalysys evolved from a University of Cambridge spin-out known as Cambridge Correlators Limited (CCL) when the team refocused on large scale HPC applications.
The Optalysys team includes specialists in software development, bioinformatics, free-space optics and optical engineering.
The company has several patents covering its groundbreaking technology.